U.S. DOD/CDMRP: Prostate Cancer Research Program (PCRP)– LOI

Clinical Consortium Award:

Supports a consortium that will facilitate the rapid execution of collaborative phase 2 or phase 2-linked phase 1 (phase 1/2) clinical trials that will bring to market high-impact, novel therapeutic interventions, which will significantly decrease the impact of prostate cancer

Funding: up to $7.6M for 4 years

Idea Development Award:

Supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to one or more of the FY25 PCRP Overarching Challenges.

Funding: up to $1.5M for 2 years

https://ebrap.org/eBRAP/public/Program.htm

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=671101